Quavonlimab, CAS 2254059-25-9

Product Description: Quavonlimab (MK-1308) is a novel anti-CTLA-4 antibody[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Perets R, et al. Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer. Ann Oncol. 2021;32(3):395-403.

CAS Number: 2254059-25-9

Molecular Weight: N/A

Compound Purity: 99.0

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: CTLA-4

• SKU: MEXHY-P99809-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99809-5
• Package Unit: 5 mg
• Quantity Unit: STK
• Conjugate: Unconjugated